Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

by Marcellin, P., Chang, T.-T., Lim, S.G., Tong, M.J., Sievert, W., Shiffman, M.L., Jeffers, L., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L.
Published 2014

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B

by Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., Chang, T.-T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S.G., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L.
Published 2014

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

by Campbell T., Smeaton L., Kumarasamy N., Flanigan T., Klingman K., Firnhaber C., Grinsztejn B., Hosseinipour M., Kumwenda J., Lalloo U., Riviere C., Sanchez J., Melo M., Supparatpinyo K., Tripathy S., Martinez A., Nair A., Walawander A., Moran L., Chen Y., Snowden W., Rooney J., Uy J., Schooley R., de Gruttola V., Hakim J., Swann E., Barnett R., Brizz B., Delph Y., Gettinger N., Mitsuyasu R., Eshleman S., Safren S., Fiscus S., Andrade A., Haas D., Amod F., Berthaud V., Bollinger R., Bryson Y., Celentano D., Chilongozi D., Cohen M., Collier A., Currier J., Cu-Uvin S., Eron J., Flexner C., Gallant J., Gulick R., Hammer S., Hoffman I., Kazembe P., Kumwenda N., Lama J., Lawrence J., Maponga C., Martinson F., Mayer K., Nielsen K., Pendame R., Ramratnam B., Sanne I., Severe P., Sirisanthana T., Solomon S., Tabet S., Taha T., van der Horst C., Wanke C., Gormley J., Marcus C., Putnam B., Ntshele S., Loeliger E., Pappa K., Webb N., Shugarts D., Winters M., Descallar R., Steele J., Wulfsohn M., Said F., Chen Y., Martin J., Bischofberger N., Cheng A., Jaffe H., Sharma J., Poongulali S., Cardoso S., Faria D., Berendes S., Burke K., Mngqibisa R., Kanyama C., Kayoyo V., Samaneka W., Chisada A.
Published 2017